ribociclib,palbociclib
novartis,pfizer
['maintain study', 'ribociclib', 'palbociclib']
maintain study shows pfs improvement in switching to ribociclib with changed endocrine therapy after progression on prior ck 4/6 inhibitor, the majority being on palbociclib. #asco22
Med Director, Clinical researcher, Breast Cancer Oncologist @bonsecours. What do oncology and bourbon have in common? ME. Tweets my own, free ?? reviews; he/his